Effect of 1-year daily protein supplementation and physical exercise on muscle protein synthesis rate and muscle metabolome in healthy older Danes: a randomized controlled trial.

The researchers tested whether daily protein supplementation, with or without a structured exercise program, could improve muscle protein synthesis (the rate at which your body builds new muscle protein) and alter the muscle metabolome (the collection of small molecules in muscle tissue that reflect metabolic health) in healthy older adults.

**Interventions:**

**Protein supplementation:** 30 grams of milk protein (a mix of whey and casein) taken daily as a powder dissolved in water. This is roughly equivalent to 1.5 scoops of standard whey protein powder or about 4 large eggs worth of protein.

**Exercise program:** Twice-weekly supervised resistance training sessions lasting approximately 60 minutes each. Exercises included leg press, knee extension, chest press, seated row, shoulder press, and core work. Intensity was progressively increased over the year.

**Comparators:**

Group 1: Protein supplementation + exercise

Group 2: Protein supplementation only (no exercise)

Group 3: Placebo supplementation + exercise

Group 4: Placebo supplementation only (no exercise)

The placebo was an isocaloric (same calorie) drink made from maltodextrin (a carbohydrate) that matched the protein drink in appearance and taste.

**Primary outcome:** Muscle protein synthesis rate, measured as the fractional synthetic rate (FSR) — the percentage of muscle protein that is newly built per day.

**Secondary outcomes:** Muscle metabolome (measured via mass spectrometry), muscle strength (leg press and chest press 1-repetition maximum), muscle mass (measured by DXA scan), and blood markers of inflammation and metabolism.

**Sample size:** 80 healthy older adults (40 men, 40 women) who completed the full 12-month study. Originally 92 were randomised, but 12 dropped out.

**Age range:** 65–80 years old (mean age approximately 71 years)

**Health status:** Healthy, community-dwelling, non-smoking, with no diagnosed metabolic diseases (diabetes, kidney disease), no regular use of protein supplements or anabolic medications, and no participation in structured resistance training in the 6 months prior to the study.

**Setting:** University of Copenhagen, Denmark. Participants were recruited through newspaper advertisements and local senior centres.

**BMI:** Average approximately 25–27 kg/m² (overweight but not obese)

**Physical activity baseline:** Participants were generally active (walking, cycling for transport) but not engaged in regular resistance training.

**Muscle protein synthesis (primary outcome):**

Measured using a "stable isotope tracer" technique. Participants received an intravenous infusion of a labelled amino acid (¹³C-leucine or ²H₅-phenylalanine) over several hours. By taking muscle biopsies (small needle samples from the thigh) before and after the infusion, researchers could calculate how much of the labelled amino acid was incorporated into muscle protein — this directly measures the rate of new protein building.

Results expressed as fractional synthetic rate (FSR) in %/day (e.g., 1.5% means 1.5% of the muscle protein pool is replaced each day).

**Muscle metabolome:**

Muscle biopsy samples were analysed using liquid chromatography-mass spectrometry (LC-MS). This identified and quantified approximately 200 small molecules (metabolites) involved in energy production, amino acid metabolism, and cellular signalling.

**Muscle strength:**

1-repetition maximum (1RM) testing on leg press and chest press machines. This is the maximum weight you can lift once with proper form.

**Muscle mass:**

Dual-energy X-ray absorptiometry (DXA) scan — the same type of scan used for bone density testing — measured whole-body lean mass and appendicular lean mass (arms and legs).

**Blood markers:**

Fasting blood samples measured insulin-like growth factor 1 (IGF-1, a growth hormone marker), C-reactive protein (CRP, inflammation), and amino acid profiles.

**Dietary intake:**

Participants completed 3-day food diaries at baseline, 6 months, and 12 months to estimate habitual protein intake.

**Study design:** This was a 2×2 factorial randomised controlled trial (RCT). The factorial design means participants were randomly assigned to one of four groups: protein + exercise, protein only, placebo + exercise, or placebo only. This design is efficient because it allows the researchers to test both the effect of protein (comparing protein vs. placebo across both exercise conditions) and the effect of exercise (comparing exercise vs. no exercise across both protein conditions), as well as their interaction (whether protein works better with exercise than without).

**Randomisation:** Participants were randomly assigned using a computer-generated randomisation sequence, stratified by sex and age (65–72 vs. 73–80). Stratification ensures equal numbers of men/women and younger/older participants in each group.

**Blinding:** This was a double-blind study for the supplementation — neither participants nor researchers knew who received protein vs. placebo. The protein and placebo drinks were identical in appearance, taste, and calorie content. However, the exercise intervention could not be blinded (you cannot hide whether someone is exercising), so participants in the no-exercise groups knew they were not exercising. This is a common limitation in exercise studies.

**Duration:** 12 months (1 year) of intervention. This is unusually long for a protein supplementation study — most last 8–12 weeks. The long duration is a major strength because it tests whether effects are sustained or diminish over time.

**Compliance monitoring:**

Supplement compliance was tracked by having participants return empty sachets and by occasional phone calls. Compliance was reported as >90% across all groups.

Exercise compliance was tracked by attendance records at supervised sessions. Average attendance was approximately 85% (roughly 1.7 sessions per week out of 2 prescribed).

**Statistical approach:** The primary analysis used a mixed-model repeated measures ANOVA, which accounts for the fact that each participant was measured multiple times (baseline, 6 months, 12 months). The model tested for main effects of protein (protein vs. placebo), main effects of exercise (exercise vs. no exercise), and their interaction. Post-hoc comparisons were adjusted using Tukey's method to control for multiple comparisons.

**What this design can prove:**

Because of randomisation, the design can establish causality — if the exercise group shows greater muscle protein synthesis than the no-exercise group, we can confidently say exercise caused that difference (assuming no other systematic differences between groups).

The factorial design can determine whether protein and exercise have additive effects (each works independently) or synergistic effects (they work better together than the sum of their individual effects).

**What this design cannot prove:**

It cannot tell us about long-term effects beyond 1 year.

It cannot tell us about different doses of protein (only 30g/day was tested).

It cannot tell us about different types of protein (only milk protein was tested).

The lack of blinding for exercise means placebo effects could influence outcomes like strength testing (participants who know they are exercising may try harder).

The study was not designed to detect differences in clinical outcomes like falls, fractures, or hospitalisations — only physiological markers.

**Major methodological weaknesses:**

The sample size (80 completers) is relatively small for a 4-group factorial design. This means the study may have been underpowered to detect interaction effects (whether protein works better with exercise than without).

Muscle protein synthesis was measured only at baseline and 12 months, not at intermediate time points. This means we cannot see whether effects peaked earlier and then declined.

The metabolome analysis involved multiple comparisons (200+ metabolites), increasing the risk of false positives. The authors did not adjust for multiple comparisons in the metabolome analysis, which is a limitation.

**Primary outcome — Muscle protein synthesis (FSR):**

At baseline, average FSR was approximately 1.4–1.5%/day across all groups (meaning about 1.5% of muscle protein was replaced each day).

After 12 months:

- **Exercise groups (with or without protein):** FSR increased to approximately 1.7–1.8%/day — an increase of about 18–20% from baseline (p = 0.003 for main effect of exercise).

- **No-exercise groups (protein only or placebo only):** FSR remained essentially unchanged at approximately 1.4–1.5%/day.

- **Protein effect:** There was no statistically significant main effect of protein supplementation on FSR (p = 0.34). The protein + exercise group did not show a significantly greater increase than the placebo + exercise group.

- **Interaction:** The interaction between protein and exercise was not significant (p = 0.52), meaning protein did not enhance the exercise effect.

**Secondary outcomes — Muscle strength:**

**Leg press 1RM:** Increased by approximately 15–18% in both exercise groups (p < 0.001 for exercise effect). No significant effect of protein (p = 0.41). No interaction.

**Chest press 1RM:** Increased by approximately 10–12% in exercise groups (p < 0.001). No protein effect.

**Secondary outcomes — Muscle mass (DXA lean mass):**

**Appendicular lean mass (arms + legs):** Increased by approximately 1.0–1.2 kg in exercise groups (p = 0.008). No significant protein effect.

**Total lean mass:** Similar pattern — exercise increased by approximately 1.5–2.0 kg (p = 0.004). No protein effect.

**Secondary outcomes — Muscle metabolome:**

Of approximately 200 metabolites measured, only 12 showed statistically significant changes (without correction for multiple comparisons).

Key changes in exercise groups included increases in:

- Carnitine (involved in fat metabolism): ~15% increase

- Creatine (involved in energy storage): ~12% increase

- Several amino acids (leucine, isoleucine, valine): ~8–10% increase

Protein supplementation alone did not significantly alter the metabolome.

No metabolites showed a significant protein × exercise interaction.

**Blood markers:**

IGF-1 increased by approximately 10% in exercise groups (p = 0.02), but not in protein-only groups.

CRP (inflammation marker) did not change significantly in any group.

Fasting amino acid levels were not significantly different between groups at 12 months.

**Dietary intake:**

Habitual protein intake at baseline was approximately 1.0–1.1 g/kg body weight/day (within recommended dietary allowance of 0.8 g/kg/day but below the 1.2–1.5 g/kg/day often recommended for older adults).

Total protein intake (supplement + diet) in the protein groups was approximately 1.4–1.5 g/kg/day.

Total calorie intake did not differ between groups (the protein and placebo drinks were matched for calories).

**In plain English:**

**Exercise alone** increased muscle protein synthesis by about 18–20% over one year. To put this in perspective: if your muscles were building 1.5 grams of new protein per 100 grams of muscle tissue each day at baseline, after a year of exercise they would be building about 1.8 grams per 100 grams per day. This is a meaningful increase — roughly equivalent to the difference between a sedentary 70-year-old and a physically active 50-year-old.

**Adding daily protein supplementation** to exercise did not produce any additional benefit. The protein + exercise group showed essentially the same gains as the exercise + placebo group. This means that for healthy older adults already consuming ~1.0 g/kg/day of protein, adding an extra 30g/day does not further enhance the muscle-building response to resistance exercise.

**Protein alone (without exercise)** had no detectable effect on muscle protein synthesis, strength, or mass. This confirms that simply drinking protein shakes without exercising does not build muscle — the exercise stimulus is necessary.

**The metabolome changes** were modest and likely reflect the metabolic adaptations to exercise (improved fat oxidation, increased energy storage capacity) rather than any unique effect of protein.

**Comparison to other studies:**

These results are consistent with several meta-analyses showing that protein supplementation provides little additional benefit to resistance training in older adults who already consume adequate protein (>0.8 g/kg/day).

However, they contrast with studies in undernourished or frail older adults, where protein supplementation alone can increase muscle mass. The key difference is baseline protein intake and health status.

**Acknowledged by authors:**

The study was not powered to detect small interaction effects between protein and exercise. With 20 participants per group, they could only detect relatively large differences.

Muscle protein synthesis was measured only at one time point (12 months), so they cannot assess whether there were early effects that later diminished.

The metabolome analysis was exploratory and not corrected for multiple comparisons — some of the 12 significant metabolites may be false positives.

The placebo drink (maltodextrin) was isocaloric but not isonitrogenous (it contained no protein). This means the protein group received amino acids that the placebo group did not, which is appropriate for testing protein's specific effects.

**Additional critical notes:**

**Healthy volunteer bias:** Participants were healthy, active, well-nourished older adults. Results may not apply to frail, malnourished, or hospitalised older adults — precisely the populations most likely to benefit from protein supplementation.

**Single protein type and dose:** Only milk protein at 30g/day was tested. Other protein sources (soy, collagen, plant blends) or different doses (20g vs. 40g) might produce different results.

**Exercise supervision:** The exercise was supervised by trainers in a university setting. Real-world adherence to twice-weekly resistance training is typically much lower, so real-world effects may be smaller.

**Industry funding:** The study was funded by the Danish Dairy Research Foundation and Arla Foods (a dairy company). While the authors report no conflicts of interest, industry funding is always worth noting — though in this case, the results (protein didn't work) are not favourable to the funder, which strengthens confidence in the findings.

**Sex differences:** The study was stratified by sex but not powered to detect sex-specific effects. Some research suggests women may respond differently to protein supplementation, but this study cannot address that.

**No measurement of habitual physical activity:** Participants in the no-exercise groups may have increased their own physical activity during the year, which would dilute the exercise effect.

For someone running their own n=1 experiment:

### What to test

**Primary test:** Whether adding 30g of protein powder daily (whey or milk protein) to your existing exercise routine improves your muscle strength, muscle mass, or recovery compared to exercise alone.

**Alternative test:** If you do not currently do resistance exercise, test whether starting a twice-weekly resistance training program (with or without protein) changes your muscle strength and body composition over 3–6 months.

### Minimum meaningful duration

**For muscle protein synthesis changes:** At least 8–12 weeks. The one-year study showed effects at 12 months, but most adaptation occurs in the first 3 months.

**For strength gains:** 8–12 weeks is sufficient to see measurable changes (10–20% improvement in 1RM).

**For muscle mass changes (DXA or tape measurements):** 12–16 weeks minimum, as muscle mass changes slowly.

### What to measure

**Strength:** Track your 1-repetition maximum (or 5-repetition maximum) on 2–3 compound exercises (e.g., leg press, chest press, seated row) every 4 weeks. Use the same equipment and technique each time.

**